DrugDashboards

Colchicum Autumnale

Colchicum Autumnale · COLCHICUM AUTUMNALE BULB 500 [hp_C]/1 · Pellet · Oral · Hahnemann Laboratories, INC.

NDC 37662-0479-01 · 200 PELLET in 1 VIAL, GLASS · UNAPPROVED HOMEOPATHIC · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover homeopathic products, which are not FDA-approved drugs.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Colchicum Autumnale (Pellet)

LabelerStrengthFirst seenLast seen
Hahnemann Laboratories, INC.COLCHICUM AUTUMNALE BULB 1 [hp_M]/1Jul 15, 2026Sep 2, 2026
Hahnemann Laboratories, INC.COLCHICUM AUTUMNALE BULB 100 [hp_C]/1Jul 15, 2026Sep 2, 2026
Hahnemann Laboratories, INC.COLCHICUM AUTUMNALE BULB 12 [hp_C]/1Jul 15, 2026Sep 2, 2026
Hahnemann Laboratories, INC.COLCHICUM AUTUMNALE BULB 200 [hp_C]/1Jul 15, 2026Sep 2, 2026
Hahnemann Laboratories, INC.COLCHICUM AUTUMNALE BULB 6 [hp_C]/1Jul 15, 2026Sep 2, 2026
Hahnemann Laboratories, INC.COLCHICUM AUTUMNALE BULB 30 [hp_C]/1Jul 15, 2026Sep 2, 2026
Hahnemann Laboratories, INC.COLCHICUM AUTUMNALE BULB 500 [hp_C]/1Jul 15, 2026Sep 2, 2026
Rxhomeo Private Limited d.b.a. Rxhomeo, IncCOLCHICUM AUTUMNALE BULB 3 [hp_X]/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Colchicum Autumnale — NDC 37662-0479-01," retrieved September 3, 2026, https://drugdashboards.com/drug/37662047901.

Free to cite with attribution — see how the data is put together.